Dr. Sunny Koipurathu Philip Jr., MD

Dr. Philip practices at Stockton Hematology Oncology Medical Group, Inc in Lodi, California.

Dr. Philip's NPI, 1578852109, was assigned on April 5, 2011. Dr. Philip graduated from St. George's University School of Medicine in 2011. Dr. Philip holds California license A151375.

Dr. Philip's primary practice is Stockton Hematology Oncology Medical Group, Inc, at 801 S Ham Ln, Lodi, CA 95242 in San Joaquin County. The practice phone is (209) 466-2626.

Dr. Philip's primary practice is Stockton Hematology Oncology Medical Group, Inc in Lodi, California. Dr. Philip is also affiliated with Adventist Health Lodi Memorial. The medical group on file is Stockton Hematology Oncology. Dmand AI also links Dr. Philip to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Philip practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Philip's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Philip is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Philip's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Philip treats.

CMS data shows 128,268 Medicare services from Dr. Philip across 44 procedure codes in 2024, for 687 Medicare patients. Medicare paid $781,956 for them.

CMS counts 687 Medicare patients who saw Dr. Philip in 2024. The largest group is 65 to 74, with 296 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Philip's median patient age at 70, with 60% women.

In 2024, Dr. Philip wrote 1,940 Medicare Part D claims for 309 patients. 75% of them were for generic drugs. CMS names the drug for 1,699 of them, across 49 drugs with 11 or more claims each, at $4,514,074 in total drug cost. In 2023, CMS named 1,581 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Philip for performance year 2024, reported as part of a group. Dr. Philip accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Philip as offering telehealth.

Dmand AI links Dr. Philip to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Philip that name 1 trial.

CMS Open Payments shows 974 general payments to Dr. Philip from 92 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,854. It also lists 1 research payment totaling $561 in 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Philip.

Dr. Philip graduated from St. George's University School of Medicine in 2011. Dr. Philip is a member of ASCO and ASH.

Dr. Philip is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.